Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery

• Eike Gallmeier ,

  Contributed equally to this work with: Eike Gallmeier, Dominik C. Bader

  Affiliation Department of Medicine 2, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯
• Dominik C. Bader ,

  Contributed equally to this work with: Eike Gallmeier, Dominik C. Bader

  Affiliation Department of Medicine 2, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯
• Lydia Kriegl,

  Affiliation Institute of Pathology, University of Munich, Munich, Germany

  ⨯
• Sabina Berezowska,

  Affiliation Institute of Pathology, University of Munich, Munich, Germany

  ⨯
• Hendrik Seeliger,

  Current address: Department of Surgery, Charité University Medical Center, Berlin, Germany

  Affiliation Department of Surgery, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯
• Burkhard Göke,

  Affiliation Department of Medicine 2, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯
• Thomas Kirchner,

  Affiliation Institute of Pathology, University of Munich, Munich, Germany

  ⨯
• Christiane Bruns,

  Affiliation Department of Surgery, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯
• Enrico N. De Toni

  * E-mail: Enrico.deToni@med.uni-muenchen.de

  Affiliation Department of Medicine 2, University Hospital Grosshadern, University of Munich, Munich, Germany

  ⨯